Essilor Stellest

In 2025, Essilor Stellest spectacle lenses received FDA approval for the first specialty myopia control glasses in the United States. Our office and skilled opticians are trained to customize frame selection and fitting to optimize vision and slow myopia progression in these lenses. Other brands such as Miyosmart and Myovision are pending FDA approval and not available to order in the US yet but are available in Canada. Myopia monitoring appointments are recommended for all Stellest wearers to ensure treatment effectiveness long term.